Insider Trading activities at Oncternal Therapeutics, Inc. (GTXI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncternal Therapeutics, Inc. (GTXI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncternal Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1260990.

Total stock buying since 2014: $9,974,292.
Total stock sales since 2014: $640,032.
Total stock option exercises since 2014: $0.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Oncternal Therapeutics, Inc.* (*GTXI*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2024	10,000	$86,256	0	$0	0	$0
2023	258,000	$76,997	0	$0	0	$0
2022	66,000	$111,061	0	$0	0	$0
2021	0	$0	3,669	$17,427	0	$0
2020	1,190,130	$2,774,371	0	$0	0	$0
2018	5,000	$83,750	34,043	$524,008	0	$0
2017	565,291	$0	0	$0	0	$0
2016	8,126,862	$6,507,968	500	$3,850	0	$0
2015	233,192	$199,879	0	$0	0	$0
2014	24,690,455	$134,010	72,883	$94,747	0	$0

Table 2. Monthly summary of insider trading at *Oncternal Therapeutics, Inc.* (*GTXI*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2024-04	3,086	$27,653	0	$0	0	$0
2024-03	6,914	$58,603	0	$0	0	$0
2023-06	28,000	$9,830	0	$0	0	$0
2023-04	230,000	$67,167	0	$0	0	$0
2022-03	5,000	$7,182	0	$0	0	$0
2022-01	61,000	$103,879	0	$0	0	$0
2021-06	0	$0	3,669	$17,427	0	$0
2020-09	71,429	$150,000	0	$0	0	$0
2020-07	1,101,289	$2,624,371	0	$0	0	$0
2020-05	17,412	$0	0	$0	0	$0
2018-07	0	$0	2,049	$30,120	0	$0
2018-06	5,000	$83,750	16,630	$316,052	0	$0
2018-01	0	$0	15,364	$177,836	0	$0
2017-09	565,291	$0	0	$0	0	$0
2016-10	7,716,049	$6,249,999	500	$3,850	0	$0
2016-06	300,000	$196,200	0	$0	0	$0
2016-03	44,000	$26,400	0	$0	0	$0
2016-01	66,813	$35,369	0	$0	0	$0
2015-12	41,907	$32,694	0	$0	0	$0
2015-05	149,977	$138,341	0	$0	0	$0
2015-04	41,308	$28,844	0	$0	0	$0
2014-11	24,545,455	$0	0	$0	0	$0
2014-09	15,000	$11,180	0	$0	0	$0
2014-08	130,000	$122,830	0	$0	0	$0

Table 3. Detailed insider trading at *Oncternal Therapeutics, Inc.* (*GTXI*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2024-04-08	Wills Robert James (Director)	Buy	3,086	8.96	27,653
2024-03-28	Wills Robert James (Director)	Buy	6,914	8.48	58,603
2023-06-14	Kaufmann Gunnar F. (Chief Scientific Officer)	Buy	3,000	.36	1,080
2023-06-12	Kaufmann Gunnar F. (Chief Scientific Officer)	Buy	25,000	.35	8,750
2023-04-14	Yazji Salim (Chief Medical Officer)	Buy	5,000	.30	1,500
2023-04-14	Breitmeyer James B (Chief Executive Officer)	Buy	50,000	.29	14,750
2023-04-13	Yazji Salim (Chief Medical Officer)	Buy	10,000	.28	2,849
2023-04-13	Leavitt Chase C. (General Counsel/Secretary)	Buy	10,000	.29	2,900
2023-04-13	Vincent Richard G (Chief Financial Officer)	Buy	30,000	.30	8,970
2023-04-13	Breitmeyer James B (Chief Executive Officer)	Buy	100,000	.29	28,999
2023-04-12	Yazji Salim (Chief Medical Officer)	Buy	10,000	.28	2,849
2023-04-12	Leavitt Chase C. (General Counsel/Secretary)	Buy	15,000	.29	4,350
2022-03-28	Vincent Richard G (Chief Financial Officer)	Buy	2,500	1.40	3,500
2022-03-25	Vincent Richard G (Chief Financial Officer)	Buy	2,497	1.47	3,678
2022-03-24	Vincent Richard G (Chief Financial Officer)	Buy	3	1.45	4
2022-01-28	Leavitt Chase C. (General Counsel/Secretary)	Buy	5,000	1.63	8,149
2022-01-28	Vincent Richard G (Chief Financial Officer)	Buy	2,500	1.65	4,125
2022-01-27	Yazji Salim (Chief Medical Officer)	Buy	10,000	1.69	16,900
2022-01-27	Leavitt Chase C. (General Counsel/Secretary)	Buy	8,500	1.78	15,130
2022-01-27	Vincent Richard G (Chief Financial Officer)	Buy	10,000	1.75	17,500
2022-01-27	Breitmeyer James B (Chief Executive Officer)	Buy	25,000	1.68	42,075
2021-06-30	Hale David F (Director)	Sale	3,669	4.75	17,427
2020-09-01	Carter Michael G (Director)	Buy	71,429	2.10	150,000
2020-07-21	Shanghai Pharmaceuticals Holding Co., Ltd. (10% Owner)	Buy	1,049,317	2.38	2,500,522
2020-07-21	Aker Hazel M (Legal Counsel)	Buy	41,972	2.38	100,019
2020-07-21	Kisner Daniel L (Director)	Buy	10,000	2.38	23,830
2020-05-21	Hale David F (Director)	Buy	17,412	.00	0
2018-07-16	Young Diane C. (VP, Chief Medical Officer)	Sale	2,049	14.70	30,120
2018-06-26	Wills Robert James (Executive Chairman)	Buy	5,000	16.75	83,750
2018-06-20	Shackelford Jason T (Prin Fin. & Acct. Officer)	Sale	9,279	19.00	176,347
2018-06-20	Doggrell Henry Patton (VP, Chief Legal Officer)	Sale	7,351	19.00	139,705
2018-01-05	Shackelford Jason T (Prin Fin. & Acct. Officer)	Sale	3,090	11.57	35,766
2018-01-05	Hanover Marc Steven (Chief Executive Officer)	Sale	7,309	11.57	84,601
2018-01-05	Doggrell Henry Patton (VP, Chief Legal Officer)	Sale	4,965	11.57	57,469
2017-09-29	Pyramid Peak Foundation	Buy	565,291	.00	0
2016-10-28	Young Diane C. (VP, Chief Medical Officer)	Sale	500	7.70	3,850
2016-10-14	Pyramid Peak Foundation	Buy	7,716,049	.81	6,249,999
2016-06-16	Wills Robert James (Executive Chairman)	Buy	200,000	.65	130,800
2016-03-01	Glass J Kenneth	Buy	44,000	.60	26,400
2016-01-26	Hanover Marc Steven (Chief Executive Officer)	Buy	4,000	.65	2,600
2016-01-25	Hanover Marc Steven (Chief Executive Officer)	Buy	12,813	.63	8,072
2016-01-19	Hanover Marc Steven (Chief Executive Officer)	Buy	25,000	.50	12,425
2016-01-15	Hanover Marc Steven (Chief Executive Officer)	Buy	22,100	.49	10,895
2016-01-14	Hanover Marc Steven (Chief Executive Officer)	Buy	2,900	.47	1,377
2015-12-24	Glass J Kenneth	Buy	100	.79	79
2015-12-23	Glass J Kenneth	Buy	600	.79	474
2015-12-22	Glass J Kenneth	Buy	1,307	.78	1,019
2015-12-21	Glass J Kenneth	Buy	39,900	.78	31,122
2015-05-19	Glass J Kenneth	Buy	24,500	1.25	30,625
2015-05-14	Wills Robert James (Executive Chairman)	Buy	36,440	.98	35,711
2015-05-13	Wills Robert James (Executive Chairman)	Buy	9,700	.88	8,536
2015-05-11	Wills Robert James (Executive Chairman)	Buy	3,860	.80	3,088
2015-05-08	Wills Robert James (Executive Chairman)	Buy	50,000	.80	40,000
2015-05-08	Doggrell Henry Patton (VP, Chief Legal Officer)	Buy	25,477	.80	20,381
2015-04-22	Glass J Kenneth	Buy	10,000	.72	7,200
2015-04-21	Glass J Kenneth	Buy	7,656	.71	5,435
2015-04-20	Glass J Kenneth	Buy	3,952	.72	2,845
2015-04-15	Glass J Kenneth	Buy	3,300	.72	2,376
2015-04-10	Glass J Kenneth	Buy	16,400	.67	10,988
2014-11-14	Pyramid Peak Foundation	Buy	24,545,455	.00	0
2014-09-23	Hanover Marc Steven (Interim CEO, President and COO)	Buy	5,000	.75	3,750
2014-09-17	Hanover Marc Steven (Interim CEO, President and COO)	Buy	10,000	.74	7,430
2014-08-21	Hanover Marc Steven (Interim CEO, President and COO)	Buy	10,000	1.00	10,000
2014-08-20	Hanover Marc Steven (Interim CEO, President and COO)	Buy	10,000	1.00	10,000
2014-08-19	Hanover Marc Steven (Interim CEO, President and COO)	Buy	8,348	1.01	8,448
2014-08-15	Hanover Marc Steven (Interim CEO, President and COO)	Buy	1,652	1.00	1,652
2014-08-08	Hanover Marc Steven (Interim CEO, President and COO)	Buy	10,000	.95	9,530
2014-08-08	Doggrell Henry Patton (VP, Chief Legal Officer)	Buy	10,000	.97	9,750
2014-08-07	Shackelford Jason T (Prin Fin. & Acct. Officer)	Buy	10,000	.92	9,170
2014-08-07	Hanover Marc Steven (Interim CEO, President and COO)	Buy	50,000	.92	45,940
2014-06-06	Dalton James T (VP, Chief Scientific Officer)	Sale	72,883	1.30	94,747

Insider trading activities including stock purchases, stock sales, and option exercises of GTXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oncternal Therapeutics, Inc. (symbol GTXI, CIK number 1260990) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month